Amicus Therapeutics, Inc. (FOLD)
9.85
-0.05
(-0.51%)
USD |
NASDAQ |
Dec 08, 16:00
9.85
0.00 (0.00%)
After-Hours: 17:57
Amicus Therapeutics Shareholders Equity (Quarterly): 230.42M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| ANI Pharmaceuticals, Inc. | 505.82M |
| Beam Therapeutics, Inc. | 966.00M |
| Catalyst Pharmaceuticals, Inc. | 920.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 868.81M |
| Total Liabilities (Quarterly) | 638.39M |
| Debt to Equity Ratio | 1.922 |
| Current Ratio | 2.986 |
| Net Debt Paydown Yield | 0.01% |